Hologic Inc logo

Hologic Inc HOLX

Market Closed
21 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
73. 07
+0.86
+1.19%
After Hours
$
73. 07
0 0%
17.71B Market Cap
38.79 P/E Ratio
0% Div Yield
2,048,900 Volume
3.91 Eps
$ 72.21
Previous Close
Day Range
71.81 73.37
Year Range
64.02 82.45

HOLX Chart

Hologic Inc Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Stephen P. MacMillan CEO
NASDAQ (NGS) Exchange
US4364401012 ISIN
US Country
6,990 Employees
- Last Dividend
3 Apr 2008 Last Split
21 Jun 1990 IPO Date

Overview

Hologic, Inc. is a pioneering company focused on improving women’s health through early detection and treatment, leveraging advanced diagnostics, medical imaging systems, and surgical products. Founded in 1985 with its headquarters in Marlborough, Massachusetts, Hologic operates across four distinct segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its commitment to innovation and improving patient outcomes positions Hologic as a leader in the healthcare industry, ensuring it meets the diverse needs of healthcare providers and patients alike.

Products and Services

  • Aptima Molecular Diagnostic Assays: These assays are designed to detect infectious microorganisms, playing a crucial role in the diagnosis and management of infectious diseases.
  • Aptima Viral Load Assays: Specifies viral load measurements for Hepatitis B, Hepatitis C, HIV, and human cytomegalovirus, critical for monitoring and managing these infections.
  • Aptima Bacterial Vaginosis and Candida Vaginitis Assays: Offer diagnosis solutions for vaginitis, improving patient care through accurate detection.
  • Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 Assays: Enable the detection of SARS-CoV-2, the virus responsible for COVID-19, showcasing Hologic's capacity to respond to emergent health threats.
  • ThinPrep System: Provides cytology applications, enhancing the accuracy of Pap tests for detecting cervical cancer at early stages.
  • Rapid Fetal Fibronectin Test: Aids in assessing the risk of pre-term birth, offering critical information to healthcare providers for managing pregnancies.
  • 3D Digital Mammography Systems: Revolutionizes breast cancer detection with advanced imaging technology, improving the early diagnosis of breast cancer.
  • MyoSure Hysteroscopic Tissue Removal System: Allows for the minimally invasive removal of fibroids and polyps in the uterus, contributing to enhanced patient comfort and recovery.
  • NovaSure Endometrial Ablation System: Provides treatment for abnormal uterine bleeding, offering an effective alternative to more invasive surgical procedures.
  • Fluent Fluid Management System: Delivers liquid distention during hysteroscopic procedures, ensuring operational efficiency and safety.
  • Acessa ProVu System: A minimally invasive solution for treating fibroids, demonstrating Hologic’s commitment to innovative treatment options.
  • CoolSeal Portfolio: Features bipolar vessel sealing devices designed for surgical efficiency and patient safety during procedures.
  • Horizon DXA: This dual-energy X-ray absorptiometry system is used for assessing bone density, aiding in the detection and treatment of osteoporosis.
  • Fluoroscan Insight FD Mini C-arm: A compact imaging solution for orthopedic surgical procedures, enhancing the visualization needed for minimally invasive interventions.

Contact Information

Address: 250 Campus Drive, Marlborough, MA, United States, 01752
Phone: 508 263 2900